Lipid-induced pancreatic β-cell dysfunction: focus on in vivo studies A Giacca, C Xiao, AI Oprescu, AC Carpentier, GF Lewis American Journal of Physiology-Endocrinology And Metabolism 300 (2), E255-E262, 2011 | 283 | 2011 |
Sodium Phenylbutyrate, a Drug With Known Capacity to Reduce Endoplasmic Reticulum Stress, Partially Alleviates Lipid-Induced Insulin Resistance and β-Cell Dysfunction in Humans C Xiao, A Giacca, GF Lewis Diabetes 60 (3), 918-924, 2011 | 243 | 2011 |
Pharmacological targeting of the atherogenic dyslipidemia complex: the next frontier in CVD prevention beyond lowering LDL cholesterol C Xiao, S Dash, C Morgantini, RA Hegele, GF Lewis Diabetes 65 (7), 1767-1778, 2016 | 240 | 2016 |
New insights into the regulation of chylomicron production S Dash, C Xiao, C Morgantini, GF Lewis Annual review of nutrition 35 (1), 265-294, 2015 | 198 | 2015 |
Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humans C Xiao, RHJ Bandsma, S Dash, L Szeto, GF Lewis Arteriosclerosis, thrombosis, and vascular biology 32 (6), 1513-1519, 2012 | 191 | 2012 |
Hypertriglyceridemia in the genomic era: a new paradigm GF Lewis, C Xiao, RA Hegele Endocrine reviews 36 (1), 131-147, 2015 | 183 | 2015 |
Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese … C Xiao, A Giacca, A Carpentier, GF Lewis Diabetologia 49 (6), 1371-1379, 2006 | 177 | 2006 |
Gut-liver interaction in triglyceride-rich lipoprotein metabolism C Xiao, J Hsieh, K Adeli, GF Lewis American Journal of Physiology-Endocrinology And Metabolism 301 (3), E429-E446, 2011 | 156 | 2011 |
Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans H Duez, B Lamarche, R Valéro, M Pavlic, S Proctor, C Xiao, L Szeto, ... Circulation 117 (18), 2369-2376, 2008 | 150 | 2008 |
Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrations S Dash, C Xiao, C Morgantini, K Koulajian, GF Lewis Diabetes 64 (3), 766-774, 2015 | 126 | 2015 |
Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men C Xiao, A Giacca, GF Lewis Diabetologia 51 (1), 139-146, 2008 | 126 | 2008 |
High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men S Dash, C Xiao, C Morgantini, L Szeto, GF Lewis Arteriosclerosis, thrombosis, and vascular biology 33 (12), 2895-2901, 2013 | 120 | 2013 |
Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids M Pavlic, C Xiao, L Szeto, BW Patterson, GF Lewis Diabetes 59 (3), 580, 2010 | 119 | 2010 |
Regulation of chylomicron production in humans C Xiao, GF Lewis Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 2011 | 103 | 2011 |
Regulation of chylomicron secretion: focus on post-assembly mechanisms C Xiao, P Stahel, GF Lewis Cellular and molecular gastroenterology and hepatology 7 (3), 487-501, 2019 | 99 | 2019 |
Glucagon-like peptide-2 regulates release of chylomicrons from the intestine S Dash, C Xiao, C Morgantini, PW Connelly, BW Patterson, GF Lewis Gastroenterology 147 (6), 1275-1284. e4, 2014 | 99 | 2014 |
C‐reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: Role of mitogen‐activated protein kinases L Xi, C Xiao, RHJ Bandsma, M Naples, K Adeli, GF Lewis Hepatology 53 (1), 127-135, 2011 | 85 | 2011 |
Sitagliptin, a DPP-4 inhibitor, acutely inhibits intestinal lipoprotein particle secretion in healthy humans C Xiao, S Dash, C Morgantini, BW Patterson, GF Lewis Diabetes 63 (7), 2394-2401, 2014 | 81 | 2014 |
Nucleic acid-targeting pathways promote inflammation in obesity-related insulin resistance XS Revelo, M Ghazarian, MHY Chng, H Luck, JH Kim, K Zeng, SY Shi, ... Cell reports 16 (3), 717-730, 2016 | 74 | 2016 |
The atherogenic dyslipidemia complex and novel approaches to cardiovascular disease prevention in diabetes P Stahel, C Xiao, RA Hegele, GF Lewis Canadian Journal of Cardiology 34 (5), 595-604, 2018 | 71 | 2018 |